Home | Welcome to Contract Pharma   
Last Updated Sunday, August 31 2014
Print

Search Results for 'Financial Report: AMRI'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published August 5, 2014
Cedarburg business boosts large scale manufacturing revenue Read More »
Published May 6, 2014
Decline in royalties impacts results Read More »
Published April 3, 2014
AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a s… Read More »
By Kristin Brooks
Published February 12, 2014
Achieves record contract revenues Read More »
Published November 6, 2013
Contract revenue up 16% in the quarter Read More »
Published October 16, 2013
Luther brings extensive discovery experience Read More »
Published August 6, 2013
Revenues up 19% in the quarter Read More »
Published November 6, 2012
Large-scale manufacturing revenue up 14% Read More »
Published August 1, 2012
Contract revenue down 3% in the quarter Read More »
Published August 2, 2006
AMRI 2Q Revenues: $45.6 million (-12%) 2Q Loss: $353,000* (earnings were $7.3 million in 2Q2005) YTD Revenues: $88.9 million (-12%) YTD Earnings: $1.5 million (earnings were $12.9 million YTD2005) Comments: Revenue for Discover… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On